Advertisement, Author at Pharmaceutical Business review - Page 62 of 67
Pharmaceutical Business review is using cookies

ContinueLearn More

All articles by  

Merck secures FDA approval for two HIV drugs

Delstrigo is a once-daily fixed-dose combination tablet of doravirine (100mg), lamivudine (3TC, 300mg) and tenofovir disoproxil fumarate (TDF, 300mg). Pifeltro (doravirine, 100mg) is a new non-nucleoside reverse transcriptase